Jd. Gilbert et al., Predictors of Torsades de Pointes in rabbit ventricles perfused with sedating and nonsedating histamine H-1-receptor antagonists, CAN J PHYSL, 78(5), 2000, pp. 407-414
Several nonsedating histamine H-1-receptor antagonists are associated with
torsades de pointes ventricular tachycardia. The objectives of this study w
ere to: (i) compare electrocardiographic, monophasic action potential, and
arrhythmogenic effects of sedating and nonsedating H-1-receptor antagonists
, and (ii) identify correlates of drug-induced torsades de pointes in an is
olated ventricle model. Isolated, electrically paced (1-3 Hz) rabbit ventri
cles were Langendorff-perfused with either drug-free Tyrode's solution or o
ne of the following: (i) the sedating H-1-receptor antagonist hydroxyzine (
0.1-30 mu M), (ii) cetirizine, a nonsedating metabolite of hydroxyzine (1-3
00 mu M), and (iii) the nonsedating, putatively arrhythmogenic H-1-receptor
antagonist astemizole (0.1-30 mu M). Volume conducted electrocardiographic
signals and monophasic action potentials from the periapical left ventricu
lar endocardium and epicardium were recorded. There were no apparent change
s in control (n = 15) or hydroxyzine-perfused (n = 7) hearts. Cetirizine (n
= 13) produced a mild biphasic electrocardiographic QT interval prolongati
on and was associated with early afterdepolarizations, but not with torsade
s de pointes. Astemizole (n = 11) lengthened QT intervals, and at high conc
entration (30 mu M) induced torsades de pointes in 10 of 11 hearts (P < 0.0
01 vs. all other groups). These findings are consistent with previously rep
orted repolarizing current inhibition by cetirizine, but may additionally i
ndicate "compensatory" inhibition of inward currents at higher concentratio
ns. By contrast, astemizole-induced changes are consistent with unopposed r
epolarizing current inhibition.